Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000615282 | SCV000715899 | likely benign | not specified | 2017-02-15 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Invitae | RCV001327334 | SCV001518402 | uncertain significance | Charcot-Marie-Tooth disease type 2 | 2014-07-24 | criteria provided, single submitter | clinical testing | There is no evidence to indicate that this sequence change is pathogenic. It is possible that this sequence change represents a benign polymorphism in the GARS gene, although at this time the evidence is insufficient to prove that conclusively. This sequence change does not fit the missense-only mutation spectrum of the GARS gene. This sequence change falls in the 5'UTR of the GARS gene. It does not change the protein sequence and is not predicted to affect splicing, but this prediction has not been confirmed by functional studies. This sequence change has not been reported in affected patients and has not been reported as a common polymorphism in the population. |